Back

One-year clinical outcome of aspirin-free prasugrel monotherapy following stent implantation in patients with chronic coronary syndrome: insight from ASET-JAPAN study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in percutaneous coronary intervention (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kotaro Miyashita

University of Galway, Galway (Ireland)

8 More presentations in this session

Presentation thumbnail
Twelve-month outcome of robotic assisted PCI
Doctor J. Rilinger (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Revascularization strategies in elderly patients with acute coronary syndromes and multivessel disease: comparative analysis of culprit-only vs complete revascularization
Mr A. Rocha De Almeida (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Mechanisms leading to peri-procedural myocardial infarction in patients with focal versus diffuse coronary artery disease
Doctor D. Munhoz (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Prevalance and impact of concomitant atrial fibrillation in patients undergoing percutaneous coronary intervention for acute myocardial infarction
Doctor S. Mahajan (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Association of PCI with outcomes in stable coronary artery disease
Doctor J. Price (Stony Brook, US)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in percutaneous coronary intervention (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study
thumbnail
Congress Presentation
Impact of procedural and patient-related risks on 1-year outcomes for patients with 1-month DAPT followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources